Patient Engagement

TORONTO – October 31, 2026 -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) has enlisted Emmy Award-winning broadcaster Montel Williams for its next Let's Huddle patient webinar on November 5, 2026, at 3:00 p.m. ET, extending the reach of its prostate care outreach program.

Williams will join host Leonard Wheeler, Profound's Global Patient Ambassador, to discuss health advocacy, resilience, informed healthcare decisions and protecting quality of life. Advance registration is required, and an archived recording will be posted on the Let's Huddle website after the live event.

Let's Huddle targets men and families navigating prostate care

Let's Huddle is a global patient community offering education, connection and support through the prostate care journey. Wheeler is a former professional football player with an eight-year NFL career, a Co-Executive Director for NFL Legends and a prostate cancer survivor.

United States – October 27, 2026 -- IntelePeer is marketing its SmartAgent Agentic AI platform to university dental schools, arguing that manual scheduling, billing follow-up and recall processes cost revenue and shape how students understand clinic operations.

Student clinics face higher no-show rates and thinner billing capacity

IntelePeer says no-shows in student clinics run higher than in private practice because the patient base skews toward price-sensitive individuals with weaker ties to a provider. Revenue recovery is further complicated by delayed billing cycles and the complexity of student-driven charting. Recalls and post-visit follow-up often depend on whichever staff member has time.

Barcelona – October 18, 2026 -- United European Gastroenterology (UEG) has launched a Patient Representatives Advisory Board (PRAB) at UEG Week 2026, giving patient groups a formal channel into its public affairs activities across Europe.

PRAB builds on the 2025 Digestive Health Roundtable Manifesto

The board follows UEG's Digestive Health Roundtable 2025 and its Manifesto, which called for patients to be recognised as co-creators of digestive health policy, research and care.

The PRAB is a structured, independent advisory body. It will provide patient-centred input into UEG's public affairs work and, where relevant, its wider activities. It also creates a formal interface between UEG and the European patient community, with the aim of identifying challenges shared across digestive diseases.

Oxford – October 15, 2026 -- Brainomix has partnered with the Pulmonary Fibrosis Foundation (PFF) to test how patients and caregivers respond when its FDA-cleared, CE-marked e-Lung quantitative CT analysis is built into clinicians' assessment workflow for pulmonary fibrosis (PF) and other fibrotic interstitial lung diseases (ILD).

Patient research targets how CT metrics shape treatment conversations

The multi-phase initiative will examine how objective quantitative CT metrics could improve clinicians' understanding of disease change over time. It will also assess how patients experience and understand those insights.

Riyadh – October 12, 2026 -- Bristol Myers Squibb (BMS) employees in Saudi Arabia assembled and personalized more than 70 'Small Wins' toolkits for people living with schizophrenia, in partnership with the Saudi Schizophrenia Association ('Ehtiwaa'). The project was part of the 12th edition of BMS's annual Global Patient Week.

Ehtiwaa and BMS design a four-step kit to build daily motivation

The 'Small Wins: Everyday Activity & Motivation' toolkit guides patients through four steps: pick a card, try the activity, recognize the win, and add it to a jar. Each kit contains activity cards with optional suggestions such as listening to a favorite song, spending a few minutes outside or tidying one small space. A 'Small Wins Jar' with paper slips lets users record daily moments of joy. Each kit also carries a handwritten note from a BMS volunteer.

Philadelphia – September 22, 2026 -- Health Union and DTC Perspectives have launched a strategic partnership to stage an invitation-only executive summit focused on redefining commercial models for rare disease and niche oncology marketing.

Summit convenes senior biopharma marketers in Boston on November 5, 2026

The Rare Marketing Summit: Redefining the Commercial Model for Rare Disease will run from 10:00 AM to 4:00 PM at The Westin Copley Place in Boston, MA, followed by a cocktail reception. Attendance is capped to preserve intimate peer exchange among senior-level biopharma marketing leaders.

Atlanta – September 16, 2026 -- Medication nonadherence costs the U.S. healthcare system as much as $300 billion annually, a gap Response Media is targeting with the launch of a new health and life sciences practice called RE:HEALTH.

Response Media debuts AdherenceIQ to predict patient drop-off before it happens

The agency introduced AdherenceIQ, a proprietary AI-powered behavioral intelligence platform designed to predict which patients will discontinue therapy and why. The tool combines behavioral science, privacy-compliant AI and advanced analytics to identify emotional and functional barriers to treatment, including concerns about side effects, necessity, distrust and stigma.